| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,447 |
9,902 |
$5.62M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,916 |
13,311 |
$3.62M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,445 |
2,789 |
$1.98M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,193 |
6,166 |
$429K |
| 71045 |
Radiologic examination, chest; single view |
3,280 |
2,701 |
$338K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,543 |
3,012 |
$269K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,065 |
2,491 |
$216K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,292 |
3,018 |
$142K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
750 |
696 |
$118K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,477 |
2,181 |
$108K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,889 |
480 |
$95K |
| 80053 |
Comprehensive metabolic panel |
15,385 |
12,838 |
$88K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,117 |
14,233 |
$68K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,170 |
1,836 |
$46K |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
1,592 |
1,107 |
$44K |
| 70450 |
Computed tomography, head or brain; without contrast material |
99 |
81 |
$44K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,285 |
1,125 |
$43K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
836 |
709 |
$43K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
536 |
382 |
$41K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
720 |
187 |
$38K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,790 |
2,242 |
$33K |
| 36415 |
Collection of venous blood by venipuncture |
8,725 |
7,361 |
$26K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
850 |
804 |
$23K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
14 |
12 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
453 |
438 |
$19K |
| 95811 |
|
36 |
13 |
$16K |
| 59025 |
Fetal non-stress test |
103 |
60 |
$15K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
212 |
186 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
212 |
196 |
$13K |
| 81001 |
|
7,912 |
6,626 |
$13K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
766 |
698 |
$11K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
395 |
214 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
84 |
73 |
$10K |
| J2704 |
Injection, propofol, 10 mg |
406 |
272 |
$8K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
42 |
39 |
$7K |
| 84484 |
|
1,125 |
931 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
91 |
66 |
$6K |
| 76801 |
|
25 |
25 |
$6K |
| 84703 |
|
1,103 |
1,015 |
$6K |
| 83690 |
|
1,363 |
1,227 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
289 |
202 |
$4K |
| 83735 |
|
1,120 |
982 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
232 |
178 |
$3K |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
64 |
25 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
205 |
187 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
93 |
55 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
189 |
160 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
110 |
76 |
$2K |
| 83880 |
|
70 |
64 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
61 |
54 |
$1K |
| 81003 |
|
730 |
656 |
$675.88 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
35 |
30 |
$638.56 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
32 |
24 |
$508.80 |
| 84443 |
Thyroid stimulating hormone (TSH) |
61 |
53 |
$458.33 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
135 |
101 |
$442.58 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
16 |
12 |
$355.21 |
| A9270 |
Non-covered item or service |
232 |
190 |
$261.53 |
| 85610 |
|
96 |
88 |
$227.51 |
| 99406 |
|
17 |
15 |
$212.55 |
| 80305 |
|
27 |
25 |
$148.20 |
| 85379 |
|
15 |
15 |
$103.55 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
16 |
12 |
$36.27 |
| 85730 |
|
15 |
15 |
$29.22 |